The Brown University Child and Adolescent Psychopharmacology Update This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Medicaid problem: Youth with severe opioid use disorder not treated appropriately
More than one out of four adults addicted to heroin in publicly funded treatment get medication‐assisted treatment (MAT), while fewer than three out of 100 adolescents and young adults get MAT, researchers have found. Recently, the American Academy of Pediatrics recommended that MAT be provided to young people. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - July 26, 2017 Category: Psychiatry Tags: Substance Use Disorders Source Type: research

For best ADHD outcomes, contact patient soon after medication initiation and get teacher ratings for a year afterward
Knowing how to best predict patient outcomes in care for attention‐deficit hyperactivity disorder (ADHD) is essential if community‐based pediatric treatment is to be as successful as possible. However, the evidence base for measuring quality care for ADHD is poor. The most common and effective treatment for decreasing ADHD symptoms is medication, but those decreases can be made even bigger by adding certain practices to the medication. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - June 27, 2017 Category: Psychiatry Tags: ADHD Source Type: research

FDA approves generic Strattera
On May 30, the U.S. Food and Drug Administration approved the first generic versions of Strattera (atomoxetine) to treat attention‐deficit hyperactivity disorder (ADHD) in pediatric and adult patients. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - June 27, 2017 Category: Psychiatry Tags: From the FDA Source Type: research

Research Roundup
Risk factors for problem behaviors in preterm children: Maternal depression, gestational age, and socioeconomic challenges Many teens use cigarettes worldwide — and half of them want to quit FBI investigates maker of genetic tests for opioid addiction susceptibility (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - June 27, 2017 Category: Psychiatry Tags: Research Roundup Source Type: research

NIH undertakes public ‐private opioid initiative
The National Institute on Drug Abuse (NIDA), under the leadership of Francis S. Collins, M.D., Ph.D., director of the National Institute of Health (NIH), is moving forward to establish a public‐private partnership addressing three major areas: (1) new and innovative medications to treat opioid use disorders and for overdose prevention and reversal; (2) safe, effective and nonaddictive strategies to manage chronic pain; and (3) neurobiology of chronic pain. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - June 27, 2017 Category: Psychiatry Tags: News Source Type: research

Changing attitudes complicate discussions around marijuana use during pregnancy
An expert in substance use disorders and pregnancy, and co‐author of a journal article on the implications of marijuana use during pregnancy, observes numerous inconsistencies in the way health care professionals and policymakers address this increasingly sensitive topic. In an interview with CPU, Virginia Commonwealth University professor Mishka Terplan, M.D., M.P.H., said providers who work with pregnant women offer their patients limited information about risks for a number of reasons, including ignorance about the existence of what is actually a significant body of research. (Source: The Brown University Child and Ad...
Source: The Brown University Child and Adolescent Psychopharmacology Update - June 27, 2017 Category: Psychiatry Tags: What's New in Research Source Type: research

Young and addicted to heroin: The path to recovery for one patient
Five years ago, Zachary Siegel, now a journalist concentrating on drug policy who is open about his opioid addiction history, found himself at the crossroads of the rehab and the medication‐assisted treatment (MAT) worlds. He was injecting heroin daily and needed help. Finding it was very difficult. He describes his path to recovery as a “winding road,” and recently gave CPU an interview on what that road entailed for him. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - June 27, 2017 Category: Psychiatry Tags: Substance Use Disorders Source Type: research

SSRIs for children and adolescents: NIMH trials show better efficacy than meta ‐analyses indicate
On one side: meta‐analyses of studies suggesting that antidepressants are no better than placebo for children and adolescents with depression. On the other: federally supported studies that do show efficacy. This other side is discussed in a recent literature review, in which psychiatrist John T. Walkup, M.D., explains the complexities needed to understand the literature and, in particular, the strengths and weaknesses of meta‐analysis. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - May 25, 2017 Category: Psychiatry Tags: Depression Source Type: research

Warnings about certain lead tests for children and adults
The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention (CDC) are warning Americans that certain lead tests manufactured by Magellan Diagnostics may provide inaccurate results for some children and adults in the United States. The CDC recommends that parents of children younger than 6 years (72 months) of age and currently pregnant women and nursing mothers who have been tested for lead exposure consult a health care professional about whether they should be retested. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - May 25, 2017 Category: Psychiatry Tags: From the FDA Source Type: research

Research Roundup
Few adverse events in RCT of atomoxetine in treatment of ADHD symptoms in children with ASD AACAP expresses concern about AHCA Bupropion may have benefits for ADHD (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - May 25, 2017 Category: Psychiatry Tags: Research Roundup Source Type: research

Conversion therapy ban still stalled in New York
While conversion therapy legislation continues to be stalled in the New York Senate, an unprecedented gathering of psychiatrists, social workers, and psychologists met at the state capitol April 25 to urge lawmakers to support the bill that would prohibit mental health professionals from engaging in efforts to change a minor's sexual orientation. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - May 25, 2017 Category: Psychiatry Tags: News Source Type: research

MDE in adolescents linked to chronic physical health conditions: SAMHSA and AAP
A new report released by the Substance Abuse and Mental Health Services Administration (SAMHSA) compares chronic physical health conditions, like obesity, asthma and bronchitis, among adolescents with and without a major depressive episode (MDE). The study found that several indicators of chronic health problems were associated with a great likelihood of an MDE. The data come from SAMHSA's National Surveys on Drug Use and Health. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - May 25, 2017 Category: Psychiatry Tags: What's New in Research Source Type: research

Risks of maternal antidepressant use not as severe as once thought
Contrary to previous research that antidepressant use in early pregnancy increases the risk of autism and attention‐deficit hyperactivity disorder (ADHD) in children, a large‐scale analysis led by University of Indiana researchers found fewer risks than previously thought from exposure to antidepressant medications during the initial stages of pregnancy. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - May 25, 2017 Category: Psychiatry Tags: In ‐utero Exposure Source Type: research

Teen use of cannabis may cause cognitive and affective problems in adulthood
Exposure to cannabis in adolescence is associated with possible harmful cognitive and affective outcomes in adulthood, researchers have found. They conducted a literature search examining the potential effects of exposure to cannabis and related synthetic cannabinoids during adolescence. They found that regardless of whether cannabis causes these consequences, youth who are exposed are also at higher risk for potential psychiatric morbidity and learning problems, as well as suicidality and addiction as adults. The earlier the onset of cannabis use, the higher the risk for problems in adulthood, according to the review. (So...
Source: The Brown University Child and Adolescent Psychopharmacology Update - April 24, 2017 Category: Psychiatry Tags: Substance Use Disorders Source Type: research

Medical marijuana: No such thing … yet
In February, the Food and Drug Administration quietly released an update on its views on medical marijuana. The agency clearly states that regardless of what states have done to remove restrictions on marijuana, only the FDA can approve safe and effective drugs. Below is its policy. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - April 24, 2017 Category: Psychiatry Tags: From the FDA Source Type: research